Suppression of craving and withdrawal in humans addicted to narcotics or amphetamines by administration of alpha-methyl-para-tyrosine (AMPT) and 5-butylpicolinic acid (fusaric acid) treatment of narcotic and amphetamine addiction in humans: preliminary report.
D000328:Adult; D000662:Amphetamines; D005669:Fusaric Acid / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008781:Methyltyrosines / Q000627:therapeutic use*; D008875:Middle Aged; D010848:Picolinic Acids / Q000627:therapeutic use*; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy*; D019966:Substance-Related Disorders / Q000188:drug therapy*
D000662:Amphetamines; D008781:Methyltyrosines; D010848:Picolinic Acids; D005669:Fusaric Acid